Urological Devices | Market Insights | Europe (Supplemental) | 2021
Driven by product innovation and an aging population, the European urological device market will grow at a modest rate through 2029 despite the impact of the ongoing COVID-19 pandemic. Revenue growth will be driven by ongoing product innovation and an increasing aging population and an associated rise in cases of urological diseases such as UI, stones, BPH, prostate and bladder cancer, and ED; however, limited capital equipment budgets among European health care facilities and prevailing preferences for established treatment methods will hinder the adoption of newer, premium-priced technology to some degree, hampering overall market growth.
This Medtech 360 Report provides high-level market metrics for urological devices in Europe, including country-level data for major countries and aggregate data for the rest of Europe, across a 10-year period.
